Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

0.61
Delayed Data
As of 3:59pm ET
 +0.0198 / +3.35%
Today’s Change
0.53
Today|||52-Week Range
1.55
-41.90%
Year-to-Date

Today’s Trading

Previous close0.59
Today’s open0.59
Day’s range0.56 - 0.61
Volume222,940
Average volume (3 months)1,030,613
Market cap$54.0M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+47.22%
Earnings growth (this year)+15.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+97.16%
P/E ratioNM
Price/Sales6.13
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
TLOGTetraLogic Pharmaceu...0.000.00%
PARNParnell Pharmaceutic...+0.05+1.23%
IPCIIntelliPharmaCeutics...-0.06-2.63%
STDYSteadymed Ltd-0.06-1.54%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$15.2M
Annual profit (last year)-$16.5M
Net profit margin-108.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry Russell Smith
Corporate headquarters
San Diego, California

Forecasts

Partner Offers